The table below shows CAPRICOR THERAPEUTICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$29.25M
-$6.43M
-$1.27M
$4.21M
$24.05M
-$3.33M
Capital expenditure
$5.12M
$896.01K
$608.59K
$347.69K
$567.62K
$36.91K
Investing cash flow
-$154.64M
$23.89M
-$9.50M
-$3.21M
-$625.36K
-$36.91K
Dividends paid
-
-
-
-
CAPR operating cash flow (10-K history)
CAPRICOR THERAPEUTICS, INC. reported operating cash flow of -$69.81M for fiscal year 2025. That is down 74.5% from -$40.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$14.45M (FY 2016) to -$69.81M. Figures come from the company's audited annual reports as filed with the SEC.